Hepatitis Monthly
Wenxiang Liu1, Yongmei Cao2, Tao Wang1, Guoan Xiang3, 
Jiangyang Lu4,*, 
Jinqian Zhang5,**, 
Peng Hou1,***The mutations of LHBs in pre-S, especially in pre-S2, are definitive in hepatocellular carcinoma (HCC) associated with HBV. However, the mechanisms of the N-glycosylation modification in LHBs are unclear. The N-glycosylation modification of LHBs affects Endoplasmic Reticulum stress, cell proliferation and its secretion which was further studied.
The objectives of our studies was to indentified that modification of LHBs by N glycosylation modulate their secretion, affect ER stress or expression of cycling, cell cycle and proliferation.
The LHBs was mutated; then expression of proteins related to endoplasmic reticulum stress and EAED path of L02 cells affected by LHBs and its mutations was evaluated. LHBs proteins bound to multiubiquitin chains and its glycosylation motif were studied. The subcellular localization and secretion of LHBs and its mutations were identified. The effect on cell cycle and proliferation by LHBs and its mutations were detected.
These data demonstrated that the N-glycosylation motifs of LHBs were associated with ER stress. The N15S, N123S, and N177S mutated LHBs proteins could induce overexpression of EDEM in L02 cells. LHBs and its mutated proteins contained p62-derived UBA domain, which could affect expression of cyclins. The subcellular localization of LHBs in endoplasmic reticulum was similar to its mutations. The secretion of LHBs was blocked by N320K mutation, which could induce an increase in G1 phase and inhibition of S phase, and inhibited mitotic entry.
In conclusion, our studies powerfully demonstrated that modification of LHBs by N glycosylation could modulate their secretion, affect ER stress or expression of cycling, cell cycle and proliferation. The N320K may be the key sites N-linked glycosylation modification of LHBs. It may be a mechanism of HBV-induced HCC.
© 2013, Author(s). This open-access article is available under the Creative Commons Attribution 4.0 (CC BY 4.0) International License (https://creativecommons.org/licenses/by/4.0/), which allows for unrestricted use, distribution, and reproduction in any medium, provided that the original work is properly cited.
Poortahmasebi V, Poorebrahim M, Ghaziasadi A, Abazari MF, Mozhgani S, et al. Analysis of Antigenic and Conformational Changes in Hepatitis B Surface Antigen (HBsAg) Identified in Iranian Patients with Chronic Hepatitis B. Hepat Mon. 2017;17(9):e57882. doi: https://doi.org/10.5812/hepatmon.57882
Rezaee R, Poorebrahim M, Najafi S, Sadeghi S, Pourdast A, et al. Impacts of the G145R Mutation on the Structure and Immunogenic Activity of the Hepatitis B Surface Antigen: A Computational Analysis. Hepat Mon. 2016;16(7):e39097. doi: https://doi.org/10.5812/hepatmon.39097
Goodarzi Z, Jazayeri S. Hepatitis B Virus PreS Variant and Hepatocellular Carcinoma. Hepat Mon. 2008;8(2):. doi:
Abbasfard Z, Kasraian L, Farhadi A, Jowkar Z, Amiri Zadeh Fard S, et al. Detection of Hepatitis B Virus Genome with Mutations Outside the Major Hydrophilic Region in the Surface Antigen Isolated from Patients with Coexisting HBsAg and Anti-HBs. Hepat Mon. 2023;23(1):e131307. doi: https://doi.org/10.5812/hepatmon-131307
Sai W, Wang L, Zheng W, Yang J, Pan L, et al. Abnormal Expression of Golgi Protein 73 in Clinical Values and Their Role in HBV-Related Hepatocellular Carcinoma Diagnosis and Prognosis. Hepat Mon. 2015;15(12):e32918. doi: https://doi.org/10.5812/hepatmon.32918
Ordering Reprints
Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC
Author(s):
